Movement Alert｜Danaher Rises 4.25% in Regular Trading, Life Sciences Sector Strengthens as Institutions Maintain Buy Rating

Market Focus06-04

On June 4, Danaher rose 4.25% in regular trading, trading at $185.375/share, with trading volume of $220 million. The rally was driven by continued strength in the Life Sciences Tools & Services sector combined with sustained institutional confidence.

On the news front, HSBC adjusted its target price for Danaher from $270 to $230 on June 3, while maintaining a Buy rating. FactSet consensus among analysts places the average target price at $244.05, implying approximately 31% upside from current levels. Meanwhile, Danaher recently completed its $9.9 billion acquisition of Masimo, further strengthening its healthcare technology portfolio and boosting market confidence in strategic integration prospects.

Within the Life Sciences Tools & Services sector, the broader group continued its upward momentum. Among individual stocks, Tempus AI rose 8.38%, Illumina rose 2.81%, IQVIA rose 2.69%, Thermo Fisher Scientific rose 2.22%, and Bruker rose 1.05%, reflecting sustained capital inflows into the sector.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1185780529?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 22:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185780529","market":"us","top_or_hot":-1,"title":"Movement Alert｜Danaher Rises 4.25% in Regular Trading, Life Sciences Sector Strengthens as Institutions Maintain Buy Rating","media":"Market Focus","content":"<p><p>On June 4, Danaher rose 4.25% in regular trading, trading at $185.375/share, with trading volume of $220 million. The rally was driven by continued strength in the Life Sciences Tools & Services sector combined with sustained institutional confidence.</p><p>On the news front, HSBC adjusted its target price for Danaher from $270 to $230 on June 3, while maintaining a Buy rating. FactSet consensus among analysts places the average target price at $244.05, implying approximately 31% upside from current levels. Meanwhile, Danaher recently completed its $9.9 billion acquisition of Masimo, further strengthening its healthcare technology portfolio and boosting market confidence in strategic integration prospects.</p><p>Within the Life Sciences Tools & Services sector, the broader group continued its upward momentum. Among individual stocks, Tempus AI rose 8.38%, Illumina rose 2.81%, IQVIA rose 2.69%, Thermo Fisher Scientific rose 2.22%, and Bruker rose 1.05%, reflecting sustained capital inflows into the sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Danaher Rises 4.25% in Regular Trading, Life Sciences Sector Strengthens as Institutions Maintain Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Danaher Rises 4.25% in Regular Trading, Life Sciences Sector Strengthens as Institutions Maintain Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-04 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 4, Danaher rose 4.25% in regular trading, trading at $185.375/share, with trading volume of $220 million. The rally was driven by continued strength in the Life Sciences Tools & Services sector combined with sustained institutional confidence.</p><p>On the news front, HSBC adjusted its target price for Danaher from $270 to $230 on June 3, while maintaining a Buy rating. FactSet consensus among analysts places the average target price at $244.05, implying approximately 31% upside from current levels. Meanwhile, Danaher recently completed its $9.9 billion acquisition of Masimo, further strengthening its healthcare technology portfolio and boosting market confidence in strategic integration prospects.</p><p>Within the Life Sciences Tools & Services sector, the broader group continued its upward momentum. Among individual stocks, Tempus AI rose 8.38%, Illumina rose 2.81%, IQVIA rose 2.69%, Thermo Fisher Scientific rose 2.22%, and Bruker rose 1.05%, reflecting sustained capital inflows into the sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DHR","symbol_name":"丹纳赫","start_time":0,"source_url":"","article_id":"1185780529","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185780529","pubTimestamp":1780584022,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 4, Danaher rose 4.25% in regular trading, trading at $185.375/share, with trading volume of $220 million. The rally was driven by continued strength in the Life Sciences Tools & Services...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DHR":"丹纳赫"},"translate_title":"动向提示|丹纳赫常规交易涨4.25%生命科学板块走强机构维持买入评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DHR":1},"content_text":"On June 4, Danaher rose 4.25% in regular trading, trading at $185.375/share, with trading volume of $220 million. The rally was driven by continued strength in the Life Sciences Tools & Services sector combined with sustained institutional confidence.On the news front, HSBC adjusted its target price for Danaher from $270 to $230 on June 3, while maintaining a Buy rating. FactSet consensus among analysts places the average target price at $244.05, implying approximately 31% upside from current levels. Meanwhile, Danaher recently completed its $9.9 billion acquisition of Masimo, further strengthening its healthcare technology portfolio and boosting market confidence in strategic integration prospects.Within the Life Sciences Tools & Services sector, the broader group continued its upward momentum. Among individual stocks, Tempus AI rose 8.38%, Illumina rose 2.81%, IQVIA rose 2.69%, Thermo Fisher Scientific rose 2.22%, and Bruker rose 1.05%, reflecting sustained capital inflows into the sector.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1185780529","isCrawlerRequest":true}